1. Academic Validation
  2. Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer

Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer

  • J Control Release. 2024 Nov:375:422-437. doi: 10.1016/j.jconrel.2024.09.018.
Hongxin Tan 1 Ziqi Shen 2 Xiaohua Wang 3 Sicheng Shu 1 Jie Deng 1 Li Lu 2 Ziyan Fan 2 Danni Hu 2 Pu Cheng 4 Xi Cao 5 Qi Huang 6
Affiliations

Affiliations

  • 1 Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • 2 School of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China.
  • 3 Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • 4 Department of Gynaecology, The Second Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address: drchengpu@zju.edu.cn.
  • 5 School of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Electronic address: caoxi@ahmu.edu.cn.
  • 6 Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Electronic address: huangqi214@163.com.
Abstract

Colorectal Cancer (CRC) is a major threat to human health, as it is one of the most common malignancies with a high incidence and mortality rate. The Cancer cell membrane (CCM) has significant potential in targeted tumor Drug Delivery due to its membrane antigen-mediated homologous targeting ability. The endoplasmic reticulum (ER) in Cancer cells plays a crucial role in Apoptosis and Ferroptosis. In this study, we developed an ER-targeted peptide-modified CCM-biomimetic nanoparticle-delivered lovastatin (LOV) nanomedicine delivery system (EMPP-LOV) for Cancer treatment. Both in vitro and in vivo experiments demonstrated that EMPP could effectively target Cancer cells and localize within the ER. EMPP-LOV modulated ER function to promote Apoptosis and Ferroptosis in tumor cells. Furthermore, synergistic antitumor efficacy was observed in both in vitro and in vivo models. EMPP-LOV induced Apoptosis in CRC cells by over-activating endoplasmic reticulum stress and promoted Ferroptosis by inhibiting the mevalonate pathway, leading to synergistic tumor growth inhibition with minimal toxicity to major organs. Overall, the EMPP-LOV delivery system, with its subcellular targeting capability within tumor cells, presents a promising therapeutic platform for CRC treatment.

Keywords

Biomimetic nanoparticles; Cell apoptosis; Colorectal cancer; Endoplasmic reticulum-targeted; Ferroptosis.

Figures
Products